Quartz determined its list of top performing stocks by the increase in their value from Jan. 1, 2019 to Dec. 31, 2019.
Below are the six best-performing pharma stocks, along with their increase in value since Jan. 1, 2019:
- Arrowhead Pharmaceuticals (523 percent)
- The Medicines Company (457 percent)
- Eidos Therapeutics (418 percent)
- Synthorx (408 percent)
- Epizyme (339 percent)
- ChemoCentryx (327 percent)
More articles on pharmacy:
Amazon’s PillPack seeking to win over new insurers in 2020
Roche buys international rights to Sarepta’s Duchenne drug for $750M
Former Aegerion sales rep defrauded insurers, stole identities to push cholesterol drug
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.